| (c) nature.com |
Retina Global is a US based 501(c)(3) nonprofit that is focused on finding sustainable solutions to the ever-increasing issues with retinal diseases in underserved areas around the world. We also manage the Orange County Eye Project in Santa Ana, CA.
Monday, October 5, 2015
Ocular treatment likely to become first Gene Therapy approved in US
Wednesday, September 30, 2015
Study Finds Anti-VEGF Therapy Safer Before Steroids for Retinal Vein Occlusion
In results from a new study that was presented at EURETINA, Aflibercept and ranibizumab were found to be safer than dexamethasone intravitreal implants for the treatment of central retinal vein occlusion.
Tuesday, September 29, 2015
First patient receives potential new treatment for wet age-related macular degeneration (AMD)
A pioneering trial of a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) has commenced at Moorfields Eye Hospital following a successful operation on a patient.
Wednesday, September 23, 2015
Mediterranean Diet May Prevent Diabetic Retinopathy
Tuesday, September 1, 2015
When do you recommend eye exam for a child with type 1 diabetes?
A new study suggests that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability to keep blood sugar levels controlled. Researchers are therefore recommending that most children with type 1 diabetes delay annual diabetic retinopathy screenings until age 15, or 5 years after their diabetes diagnosis, whichever occurs later.
Friday, August 28, 2015
AMD likely to be more in people with deficient vitamin D status
A multi-institutional team reports that vitamin D may play a
significant role in eye health, specifically in the possible prevention
of age-related macular degeneration, or AMD, among women who are more
genetically prone to developing the sight-damaging disease.
In a paper published in JAMA Ophthalmology online, the team found that women who are deficient in vitamin D and have a specific high-risk genotype are 6.7 times more likely to develop AMD than women with sufficient vitamin D status and no high risk genotype.
In a paper published in JAMA Ophthalmology online, the team found that women who are deficient in vitamin D and have a specific high-risk genotype are 6.7 times more likely to develop AMD than women with sufficient vitamin D status and no high risk genotype.
Monday, August 24, 2015
RetroSense Therapeutics Gets Approval for Clinical Trials in Retinitis Pigmentosa
| (c) nature.com |
Subscribe to:
Posts (Atom)